Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 510 of 1,261
  1. US 10231955

    Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery

    The Board of Regents of the University of Texas System · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted
  2. US 10231932

    Process of preparing pharmaceutical compositions for the treatment of CFTR mediated diseases

    Vertex Pharmaceuticals Incorporated · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted
  3. US 10231958

    Methods and compositions for enhancing chemotherapy

    The Board of Regents of the University of Texas System · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted
  4. US 10231943

    Compositions and methods for treating cardiovascular diseases

    Infirst Healthcare Limited · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted
  5. US 10231974

    Pharmaceutical composition effective in preventing the adverse effects associated with the prolonged use of dihydrofolate reductase inhibitors

    Compass Therapeutics LLC · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted
  6. US 10232059

    Functionalized magnetic nanoparticles and use in imaging amyloid deposits and neurofibrillary tangles

    The Regents of the University of California · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted
  7. US 10233172

    Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists

    Theravance Biopharma R&D IP, LLC · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted
  8. US 10231937

    Process for encapsulating soluble biologics, therapeutics, and imaging agents

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted
  9. US 10233161

    Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid

    PTC THERAPEUTICS, INC. · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted
  10. US 10233222

    Methods, compositions, diagnostics and assays for the treatment of Alzheimer's disease

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted
  11. US 10233240

    Methods for treating cholestatic liver fibrosis

    The Regents of the University of California · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted
  12. US 10233420

    Methods of recellularizing a tissue or organ for improved transplantability

    Regents of the University of Minnesota · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted
  13. US 10233250

    Human antibodies to the glucagon receptor and methods of use thereof for lowering blood glucose or ketone levels

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted
  14. US 10231929

    Solid dispersion

    Takeda Pharmaceutical Company Limited · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted
  15. US 10231949

    Inhibition of cancer cell motility

    Northwestern University · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted
  16. US 10231905

    Dental curable composition

    KURARAY NORITAKE DENTAL INC. · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted
  17. US 10233438

    Engineered primate L-methioninase for therapeutic purposes

    The Board of Regents of the University of Texas System · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted
  18. US 10231983

    Use of ACTH in assessment and prophylactic treatment of hypokalemia associated with glucocorticoid receptor modulator treatment of Cushing's syndrome patients

    Corcept Therapeutics Incorporated · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted
  19. US 10233174

    Thiocarbamate prodrugs of tofacitinib

    Theravance Biopharma R&D IP, LLC · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted
  20. US 10233206

    D-fagomine for the control of inflammatory processes related to an overactivation of the humoral immune response

    SERGIO PUMAROLA SEGURA · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted
  21. US 10232044

    Controlled release aural pressure modulator compositions and methods for the treatment of OTIC disorders

    The Regents of the University of California · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted
  22. US 10231984

    Oligomer-foscarnet conjugates

    Nektar Therapeutics · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted
  23. US 10231903

    Pharmaceutical compounding methods and systems

    MEDISCA PHARMACEUTIQUE INC. · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted
  24. US 10233191

    Fused piperidine amides as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.